{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:33:21Z","timestamp":1776454401008,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejvs.2025.07.014","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:04:39Z","timestamp":1752602679000},"page":"643-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Outpatient Pharmacist Strategy Improves Guideline Adherent Medication Prescribing in Patients with Vascular Disease"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0268-1354","authenticated-orcid":false,"given":"Aaron","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lotric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0918-5550","authenticated-orcid":false,"given":"Lauren","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thodur","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2025.07.014_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib2","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","volume":"2007","author":"Aung","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2025.07.014_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1024\/0301-1526\/a001012","article-title":"Statins and statin intensity in peripheral artery disease","volume":"51","author":"Sagris","year":"2022","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2025.07.014_bib4","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.STR.0000147965.52712.fa","article-title":"Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis","volume":"35","author":"Amarenco","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2025.07.014_bib5","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1161\/STROKEAHA.108.516450","article-title":"Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","volume":"39","author":"Sillesen","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2025.07.014_bib6","article-title":"High-intensity statin therapy is associated with improved survival in patients with peripheral artery disease","volume":"6","author":"Foley","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2025.07.014_bib7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2025.07.014_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2025.07.014_bib9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/bjs.10269","article-title":"Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm","volume":"103","author":"Bahia","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/bmj.316.7137.1043","article-title":"Smoking and risk of myocardial infarction in women and men: longitudinal population study","volume":"316","author":"Prescott","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2025.07.014_bib11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","article-title":"Mortality in relation to smoking: 50 years' observations on male British doctors","volume":"328","author":"Doll","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2025.07.014_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1586\/14779072.6.6.883","article-title":"Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease","volume":"6","author":"Bullen","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ejvs.2025.07.014_bib13","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2025.07.014_bib14","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2025.07.014_bib15","article-title":"Physician advice for smoking cessation","volume":"2013","author":"Stead","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2025.07.014_bib16","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2025.07.014_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor's Choice \u2013 European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejvs.2023.11.002","article-title":"Editor's Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"67","author":"Wanhainen","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/1472-6963-13-461","article-title":"Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials","volume":"13","author":"Cai","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejvs.2025.07.014_bib22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/1060028019864669","article-title":"The role of the clinical pharmacist in a preventive cardiology practice","volume":"53","author":"Warden","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejvs.2025.07.014_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1592\/phco.20.5.410.35048","article-title":"Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial","volume":"20","author":"Faulkner","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejvs.2025.07.014_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1592\/phco.25.3.360.61601","article-title":"Achieving cholesterol target in a managed care organization (ACTION) trial","volume":"25","author":"Straka","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejvs.2025.07.014_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12872-021-02178-0","article-title":"Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial","volume":"21","author":"Ostbring","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejvs.2025.07.014_bib26","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2025.07.014_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1517\/14740338.4.6.995","article-title":"Bupropion: risks and benefits","volume":"4","author":"Ross","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ejvs.2025.07.014_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S2213-2600(23)00184-4","article-title":"Unavailability of varenicline: a global tragedy for the fight against the tobacco epidemic","volume":"11","author":"Lang","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejvs.2025.07.014_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ejvs.2025.07.014_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ejvs.2025.07.014_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0197-2456(98)00037-3","article-title":"Power and sample size calculations for studies involving linear regression","volume":"19","author":"Dupont","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ejvs.2025.07.014_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36014","article-title":"Prescribing of statins after lower extremity revascularization procedures in the US","volume":"4","author":"Singh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejvs.2025.07.014_bib33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejvs.2022.02.007","article-title":"Gender differences in outpatient peripheral artery disease management in Germany: a population based study 2009\u20132018","volume":"63","author":"Messiha","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib34","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.ejvs.2025.07.014_bib35","series-title":"RStudio: Integrated Development Environment for R","year":"2023"},{"key":"10.1016\/j.ejvs.2025.07.014_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor's Choice \u2013 European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's Choice \u2013 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012541","article-title":"Adherence to guideline-recommended therapy-including supervised exercise therapy referral-across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry","volume":"9","author":"Saxon","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2025.07.014_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/ans.16469","article-title":"The prescription of best medical therapy following infrainguinal bypass grafting in Australia and New Zealand: a multicentre Australasian audit","volume":"91","author":"Farah","year":"2021","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib40","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2025.07.014_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010076","article-title":"Underutilization of evidence-based smoking cessation support strategies despite high smoking addiction burden in peripheral artery disease specialty care: insights from the international PORTRAIT registry","volume":"7","author":"Patel","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"Supplement_4","key":"10.1016\/j.ejvs.2025.07.014_bib42","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/ajhp\/zxae097","article-title":"Pharmacist optimization of lipid therapy in patients with peripheral vascular disease","volume":"81","author":"Tucker","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejvs.2025.07.014_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imj.15504","article-title":"Pharmacists reducing medication risk in medical outpatient clinics: a retrospective study of 18 clinics","volume":"53","author":"Snoswell","year":"2023","journal-title":"Intern Med J"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425006744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425006744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T02:38:41Z","timestamp":1763087921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588425006744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1078588425006744"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.07.014","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Outpatient Pharmacist Strategy Improves Guideline Adherent Medication Prescribing in Patients with Vascular Disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Vascular Surgery. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}